STC2 promotes cisplatin resistance through metabolic reprogramming and lactylation-mediated epigenetic regulation in cervical cancer
Acta Biochimica et Biophysica Sinica · 01.11.2026 · 58 (11) · 2609-2622
DOI: 10.3724/abbs.2026169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, online erschienen am 29.09.2026. Verfasst von Shanshan Jin und 9 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Epigenesis, Genetic, Glycoproteins. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Jin, S., Gao, D., Xiahou, Y., Tao, J., Jia, D., Huang, L., Liu, Z., Hou, S., Xie, J., & Lv, H. (2026). STC2 promotes cisplatin resistance through metabolic reprogramming and lactylation-mediated epigenetic regulation in cervical cancer. Acta Biochimica et Biophysica Sinica, 58(11), 2609-2622. https://doi.org/10.3724/abbs.2026169
Vancouver
Jin S, Gao D, Xiahou Y, Tao J, Jia D, Huang L, et al. STC2 promotes cisplatin resistance through metabolic reprogramming and lactylation-mediated epigenetic regulation in cervical cancer. Acta Biochimica et Biophysica Sinica. 2026;58(11):2609-2622. doi:10.3724/abbs.2026169
BibTeX
@article{Jin2026,
author = {Jin, Shanshan and Gao, Dongqin and Xiahou, Yaling and Tao, Junxia and Jia, Danna and Huang, Lijuan and Liu, Zhizhen and Hou, Shulin and Xie, Jun and Lv, Huimin},
title = {STC2 promotes cisplatin resistance through metabolic reprogramming and lactylation-mediated epigenetic regulation in cervical cancer},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2026},
volume = {58},
number = {11},
pages = {2609--2622},
doi = {10.3724/abbs.2026169}
}
EUVIMED